Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
152.62
+4.33 (2.92%)
Aug 12, 2026, 11:50 AM EDT - Market open
Protagonist Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Buy Maintains $145 → $170 | Buy | Maintains | $145 → $170 | +11.39% | Aug 10, 2026 |
| Wedbush | Wedbush | Buy Reiterates $173 | Buy | Reiterates | $173 | +13.35% | Aug 10, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Upgrades $186 | Buy | Upgrades | $186 | +21.87% | Aug 10, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $117 → $167 | Buy | Reiterates | $117 → $167 | +9.42% | Aug 10, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $155 | Buy | Maintains | $155 | +1.56% | Aug 6, 2026 |
| Clear Street | Clear Street | Buy Reiterates $116 → $173 | Buy | Reiterates | $116 → $173 | +13.35% | Aug 6, 2026 |
| Citi | Citi | Buy Maintains $130 → $175 | Buy | Maintains | $130 → $175 | +14.66% | Aug 6, 2026 |
| Barclays | Barclays | Buy Maintains $151 → $153 | Buy | Maintains | $151 → $153 | +0.25% | Aug 6, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.